GFAP antibody (70R-GR031)

Affinity purified Rabbit polyclonal GFAP antibody

Synonyms Polyclonal GFAP antibody, Anti-GFAP antibody, Glial Fibrillary Acid Protein antibody, Glial marker, Glial Filament Protein antibody
Specificity Human
Cross Reactivity Mouse, rat
Applications FC, IHC, WB
Immunogen GFAP antibody was raised in rabbit using the C terminus of the 50 kDa human protein as the immunogen.

Images

Specifications

Host Rabbit
Isotype IgG
Method of Purification GFAP antibody was purified by affinity chromatography.
Form & Buffer Affinity purified and supplied in PBS, with 0.02% NaN3.
Concentration 1.0 mg/ml

Usage & Assay Information

Usage Recommendations FC: 1:200-1:500, IHC: 1:100-1:200, WB: 1:500-1:1,000

Storage & Safety

Storage Store at 4 deg C for short term storage. Aliquot and store at -20 deg C for long term storage. Avoid repeated freeze/thaw cycles.
Biohazard Information This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.

General Information

Product Use Purified polyclonal GFAP antibody specific for Human GFAP for use in Flow Cytometry, Immunohistochemistry and Western Blot.
Biological Significance GFAP is one of the major intermediate filament proteins of mature astrocytes. GFAP is used as a marker to distinguish astrocytes from other glial cells during development.
Expression GFAP is expressed in the central nervous system in astrocyte cells and ependymal cells and in cells lacking fibronectin. GFAP has also been found to be expressed in glomeruli and peritubular fibroblasts taken from rat kidneys Leydig cells of the testis in both hamsters and humans, human keratinocytes, human osteocytes and chondrocytes and stellate cells of the pancreas and liver in rats.
Implications in Disease Mutations in GFAP expression cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alexander disease, also known as fibrinoid leukodystrophy, is a slowly progressing and fatal neurodegenerative disease. It is a very rare disorder which results from a genetic mutation and mostly affects infants and children, causing developmental delay and changes in physical characteristics.
Sequence Information GFAP is composed of 432 amino acids with a molecular weight of 49880 Da. GFAP is a member of the intermediate filament family.
Post-Translational Modifications GFAP is Phosphorylated by PKN1.
Database Links Entrez Gene: 2670 Human, Omim: 137780 Human, SwissProt: P14136 Human, Unigene: 514227 Human

References
Add a Paper

Sorry, but there are no references currently for this product.

Reviews

You need to be logged in to write a review. Please login here

Sorry there are currently no reviews for this product

Images

Availability: In stock

Price: $250.00
Size: 100 ug
OR
Shipping
View Our Distributors